# Neuravi, Ltd.

- Location (FDA's records): Galway, IE
- FDA decisions: 7 (2018–2025): 7 510(k) clearances
- Names in FDA's records: Neuravi, Ltd. (4); Neuravi Limited (3)
- Product codes: NRY (5), QJP (2)
- 510(k) review time since 2016: median 127 days, against 129 for FDA's reviews in the same codes and years (3 of 7 faster)
- Predicates its devices cite: 12 (8 its own); citations of its devices by later devices: 8 (8 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Concentric Medical, Inc.: 2 (https://510kreport.com/company/concentric-medical)
- Micro Therapeutics, Inc. d/b/a ev3 Neurovascular: 1 (https://510kreport.com/company/micro-therapeutics-d-b-a-ev3-neurovascular)
- Micro Therapeutics Dba Ev3 Neurovascular: 1 (https://510kreport.com/company/micro-therapeutics-dba-ev3-neurovascular)

## Its most-cited devices
- K173452: EmboTrap ll Revascularization Device (2018), cited by 3
- K193063: EMBOTRAP III Revascularization Device (2020), cited by 2
- K211338: EMBOTRAP III Revascularization Device (2021), cited by 1
- K212340: EMBOGUARD Balloon Guide Catheter (2021), cited by 1
- K212908: EmboTrap II Revascularization Device, EMBOTRAP III Revascularization Device (2021), cited by 1

## Recent decisions
- K251789: EMBOTRAP III Revascularization Device (Sep 25, 2025)
- K233924: EMBOGUARD Balloon Guide Catheter (Apr 18, 2024)
- K212340: EMBOGUARD Balloon Guide Catheter (Dec 17, 2021)
- K212908: EmboTrap II Revascularization Device, EMBOTRAP III Revascularization Device (Oct 13, 2021)
- K211338: EMBOTRAP III Revascularization Device (Jul 30, 2021)
- K193063: EMBOTRAP III Revascularization Device (Jul 14, 2020)
- K173452: EmboTrap ll Revascularization Device (May 9, 2018)

Source page: https://510kreport.com/company/neuravi